PURPOSE: Measuring quality of care for symptom management and ascertaining patient goals offers an important step toward improving palliative cancer management. This study was designed to identify systematically the quality measures and the evidence to support their use in pain, dyspnea, depression, and advance care planning (ACP), and to identify research gaps. METHODS: English-language documents were selected from MEDLINE, Cumulative Index to Nursing and Allied Health, PsycINFO (1995 to 2005); Internet-based searches; and contact with measure developers. We used terms for each domain to select studies throughout the cancer care continuum. We included measures that expressed a normative relationship to quality, specified the target population, and specified the indicated care. Dual data review and abstraction was performed by palliative care researchers describing populations, testing, and attributes for each measure. RESULTS: A total of 4,599 of 5,182 titles were excluded at abstract review. Of 537 remaining articles, 19 contained measures for ACP, six contained measures for depression, five contained measures for dyspnea, and 20 contained measures for pain. We identified 10 relevant measure sets that included 36 fully specified or fielded measures and 14 additional measures (16 for pain, five for dyspnea, four for depression, and 25 for ACP). Most measures were unpublished, and few had been tested in a cancer population. We were unable to describe the specifications of all measures fully and did not search for measures for pain and depression that were not cancer specific. CONCLUSION: Measures are available for assessing quality and guiding improvement in palliative cancer care. Existing measures are weighted toward ACP, and more nonpain symptom measures are needed. Additional testing is needed before the measures are used for accountability, and basic research is required to address measurement when self-report is impaired.
PURPOSE: Measuring quality of care for symptom management and ascertaining patient goals offers an important step toward improving palliative cancer management. This study was designed to identify systematically the quality measures and the evidence to support their use in pain, dyspnea, depression, and advance care planning (ACP), and to identify research gaps. METHODS: English-language documents were selected from MEDLINE, Cumulative Index to Nursing and Allied Health, PsycINFO (1995 to 2005); Internet-based searches; and contact with measure developers. We used terms for each domain to select studies throughout the cancer care continuum. We included measures that expressed a normative relationship to quality, specified the target population, and specified the indicated care. Dual data review and abstraction was performed by palliative care researchers describing populations, testing, and attributes for each measure. RESULTS: A total of 4,599 of 5,182 titles were excluded at abstract review. Of 537 remaining articles, 19 contained measures for ACP, six contained measures for depression, five contained measures for dyspnea, and 20 contained measures for pain. We identified 10 relevant measure sets that included 36 fully specified or fielded measures and 14 additional measures (16 for pain, five for dyspnea, four for depression, and 25 for ACP). Most measures were unpublished, and few had been tested in a cancer population. We were unable to describe the specifications of all measures fully and did not search for measures for pain and depression that were not cancer specific. CONCLUSION: Measures are available for assessing quality and guiding improvement in palliative cancer care. Existing measures are weighted toward ACP, and more nonpain symptom measures are needed. Additional testing is needed before the measures are used for accountability, and basic research is required to address measurement when self-report is impaired.
Authors: Amar A Desai; Roger Bolus; Allen Nissenson; Sally Bolus; Matthew D Solomon; Osman Khawar; Matthew Gitlin; Jennifer Talley; Brennan M R Spiegel Journal: Clin J Am Soc Nephrol Date: 2008-04-16 Impact factor: 8.237
Authors: J Randall Curtis; Seelwan Sathitratanacheewin; Helene Starks; Robert Y Lee; Erin K Kross; Lois Downey; James Sibley; William Lober; Elizabeth T Loggers; James A Fausto; Charlotta Lindvall; Ruth A Engelberg Journal: J Palliat Med Date: 2017-11-28 Impact factor: 2.947
Authors: Arif H Kamal; Margaret Gradison; Jennifer M Maguire; Donald Taylor; Amy P Abernethy Journal: J Oncol Pract Date: 2014-06-10 Impact factor: 3.840
Authors: Frederick J Meyers; Michael Carducci; Matthew J Loscalzo; John Linder; Tamara Greasby; Laurel A Beckett Journal: J Palliat Med Date: 2011-03-17 Impact factor: 2.947
Authors: Anne M Walling; Steven M Asch; Karl A Lorenz; Jennifer Malin; Carol P Roth; Tod Barry; Neil S Wenger Journal: Support Care Cancer Date: 2012-04-29 Impact factor: 3.603